November 21, 2024
- Our Services
- Platforms
- Target Solutions
- Technologies
- Service Types
- Our Science
- About Us
- Contact us
| Summary | |
|---|---|
| Cancer Type | Lung Cancer |
| Grade | NA |
| Stage | NA |
| Ethnicity | Western |
| Gender | F |
| Age | 62 |
| Pathology Diagnosis | h/o non-small cell lung cancer metastatic adenocarcinoma, mpd. Pathol comment: c/w diagnosis. approximately 30% of the tissue involved by malignant tumor in sections examined. 20% necrosis. approximately 60% malignant tumor cells present in cytospin preparation. |
| Biopsy Site | Lt pectoral |
| Treatment History | Carboplatin, Taxol, Gemzar, Zometa |
| Pathology QC | Poorly differentiated adenocarcinoma with massive necrosis (P0), mucinous adenocarcinoma (P4, P7) |
| Special Features | NA |
| Mouse Strain | NOD SCID |
| TMA | TMA-HP-LU-210 |
| Viral Status in PDX | NA |
| Available In | CB_SD, CB_CN |
| RNA Seq | P1 |
| Exome Seq | NA |
